
EQL Pharma Investor Relations Material
Latest events

Q4 24/25
EQL Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EQL Pharma
Access all reports
EQL Pharma AB engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. It specializes in the treatment of male infertility by proactive production and sale of medicines under its owned trademarks to end consumers, private actors as well as public hospitals and pharmacies. The company was founded in 2006 and is based in Lund, Sweden.
Key slides for EQL Pharma


CMD 2025
EQL Pharma


ABGSC Investor Days
EQL Pharma
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
EQL
Country
🇸🇪 Sweden